Drawing for VISTELA

USPTO serial 78170595

VISTELA

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
BERK, STEVEN R
Law office
FILE REPOSITORY (FRANCONIA)

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with VISTELA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Warren L. Zeserman

WARREN L ZESERMAN PFIZER INC . / LEGAL DIVISION150 E 42ND STNEW YORK, NJ 10017UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological disorders, urogenital disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, obesity, inflammation, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, viral disorders, fungal disorders; pharmaceutical preparations, namely, cholesterol preparations, smoking cessation preparations, dermatological preparations, gynecological preparations, osteoporosis preparations, opthalmological preparationsABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 19, 2004OP.TOPPOSITION TERMINATED NO. 999999—
Jan 5, 2004OP.TOPPOSITION TERMINATED NO. 999999—
Dec 8, 2003OP.TOPPOSITION TERMINATED NO. 999999—
Dec 2, 2003ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Oct 30, 2003OP.TOPPOSITION TERMINATED NO. 999999—
Oct 30, 2003OP.TOPPOSITION TERMINATED NO. 999999—
Oct 30, 2003OP.DOPPOSITION DISMISSED NO. 999999—
Jul 11, 2003OP.IOPPOSITION INSTITUTED NO. 999999—
Jun 13, 2003ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
May 13, 2003PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 23, 2003NPUBNOTICE OF PUBLICATION—
Mar 18, 2003CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 10, 2003DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance